{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:01:58Z","timestamp":1789664518737,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T00:00:00Z","timestamp":1357862400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>IgA nephropathy (IgAN) is the most common glomerulonephritis, which may also coexist with other diseases. We present two patients with an unusual coincidence of IgAN and Fabry disease (FD).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 26 year-old man underwent a renal biopsy in February 2001. Histopathology showed very advanced IgAN and vascular changes as a result of hypertension. Because of his progressive renal insufficiency the patient began hemodialysis in August 2001. By means of the blood spot test screening method the diagnosis of FD was suspected. Low activity of alpha-galactosidase A in the patient\u2019s plasma and leukocytes and DNA analysis confirmed the diagnosis of FD. Enzyme replacement therapy started in July 2004. Then the patient underwent kidney transplantation in November 2005. Currently, his actual serum creatinine level is 250 \u03bcmol\/l. Other organ damages included hypertrophic cardiomyopathy, neuropathic pain and febrile crisis. After enzyme replacement therapy, myocardial hypertrophy has stabilized and other symptoms have disappeared. No further progression of the disease has been noted.<\/jats:p>\n            <jats:p>The other patient, a 30 year-old woman, suffered from long-term hematuria with a good renal function. Recently, proteinuria (2.6 g\/day) appeared and a renal biopsy was performed. Histopathology showed IgAN with remarkably enlarged podocytes. A combination of IgAN and a high suspicion of FD was diagnosed. Electron microscopy revealed dense deposits in paramesangial areas typical for IgAN and podocytes with inclusive zebra bodies and myelin figures characteristic of FD. FD was confirmed by the decreased alpha-galactosidase A activity in plasma and leukocytes and by DNA and RNA analysis. Enzyme replacement therapy and family screening were initiated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results emphasize the role of complexity in the process of diagnostic evaluation of kidney biopsy samples. Electron microscopy represents an integral part of histopathology, and genetic analysis plays a more and more important role in the final diagnosis, which is followed by causal treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-14-6","type":"journal-article","created":{"date-parts":[[2013,1,11]],"date-time":"2013-01-11T03:14:29Z","timestamp":1357874069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The coincidence of IgA nephropathy and Fabry disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Dita","family":"Maixnerov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladim\u00edr","family":"Tesa\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Ry\u0161av\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Reiterov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Poup\u011btov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Dvo\u0159\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubor","family":"Gol\u00e1\u0148","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Nepra\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kidorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Merta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Honsov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,11]]},"reference":[{"key":"425_CR1","first-page":"319","volume":"24","author":"JR Johnson","year":"2003","unstructured":"Johnson JR, John Feehally J: IgA nephropathy and Henoch-Schonlein Nephritis. Clin Nephrol. 2003, 24: 319-329.","journal-title":"Clin Nephrol"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00467-006-0176-5","volume":"21","author":"C Whybra","year":"2006","unstructured":"Whybra C, Schwarting A, Kriegsmann J, Gal A, Mengel E, Kampmann C, Baehner F, Schaefer E, Beck M: IgA nephropathy in two adolescent sisters heterozygous for Fabry disease. Pediatr Nephrol. 2006, 21: 1251-1256. 10.1007\/s00467-006-0176-5.","journal-title":"Pediatr Nephrol"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","volume":"33","author":"H Poup\u011btov\u00e1","year":"2010","unstructured":"Poup\u011btov\u00e1 H, Ledvinov\u00e1 J, Bern\u00e1 L, Dvo\u0159\u00e1kov\u00e1 L, Ko\u017eich V, Elleder M: The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis. 2010, 33: 387-396. 10.1007\/s10545-010-9093-7.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"425_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ndt\/gfl528","volume":"22","author":"M Merta","year":"2007","unstructured":"Merta M, Reiterova J, Ledvinova J, Poupetov\u00e1 H, Dobrovolny R, Rysav\u00e1 R, Maixnerov\u00e1 D, Bultas J, Mot\u00e1n J, Slivkova J, Sobotova D, Smrzova J, Tesar V: A nationwide blood spot screening study for Fabry disease in the Czech Republic haemodialysis patient population. Nephrol Dial Transplant. 2007, 22 (1): 179-186.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"425_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1096-7192(02)00012-4","volume":"76","author":"J Shabbeer","year":"2002","unstructured":"Shabbeer J, Yasuda M, Luca E, Desnick RJ: Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype. Mol Genet Metab. 2002, 76 (1): 23-30. 10.1016\/S1096-7192(02)00012-4.","journal-title":"Mol Genet Metab"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/ndt\/17.7.1197","volume":"17","author":"JV Donadio","year":"2002","unstructured":"Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM: Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002, 17: 1197-1203. 10.1093\/ndt\/17.7.1197.","journal-title":"Nephrol Dial Transplant"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.semnephrol.2004.01.001","volume":"24","author":"G D\u2019Amico","year":"2004","unstructured":"D\u2019Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004, 24: 179-196. 10.1016\/j.semnephrol.2004.01.001.","journal-title":"Semin Nephrol"},{"key":"425_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","volume":"83","author":"R Dobrovolny","year":"2005","unstructured":"Dobrovolny R, Dvo\u0159\u00e1kova L, Ledvinov\u00e1 J, Magage S, Bultas J, Lubanda JC, Elleder M, Karetova D, Pavl\u00edkov\u00e1 M, H\u0159eb\u00ed\u010dek M: Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med. 2005, 83: 647-654. 10.1007\/s00109-005-0656-2.","journal-title":"J Mol Med"},{"key":"425_CR9","first-page":"28","volume":"20","author":"AN Martinez","year":"2003","unstructured":"Martinez AN, Hernandez BFJ, Martin PG: Fabry\u2019s disease associated with rheumatoid arthritis. Multisystemic crossroads. An Med Interna. 2003, 20: 28-30.","journal-title":"An Med Interna"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10545-007-0513-2","volume":"30","author":"P Martinez","year":"2007","unstructured":"Martinez P, Aggio M, Rozenfeld P: High incidence of autoantibodies in Fabry disease patients. J Inherit Metab Dis. 2007, 30: 365-369. 10.1007\/s10545-007-0513-2.","journal-title":"J Inherit Metab Dis"},{"key":"425_CR11","first-page":"1189","volume":"34","author":"K Majima","year":"1992","unstructured":"Majima K, Ishizaki T, Inoue T, Hori Y, Egami J, Oohara A, Nishida H, Miyake Y, Matsumoto S, Kinoshita E: A case of Fabry\u2019s disease associated with lupus nephritis. Nihon Jinzo Gakkai Shi. 1992, 34: 1189-1194.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"425_CR12","first-page":"475","volume":"16","author":"P Rahman","year":"1998","unstructured":"Rahman P, Gladman DD, Wither J, Silver MD: Coexistence of Fabry\u2019s disease and systemic lupus erythematosus. Clin Exp Rheumatol. 1998, 16: 475-478.","journal-title":"Clin Exp Rheumatol"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000183006","volume":"34","author":"E Rosenmann","year":"1983","unstructured":"Rosenmann E, Kobrin I, Cohen T: Kidney involvement in systemic lupus erythematosus and Fabry\u2019s disease. Nephron. 1983, 34: 180-184. 10.1159\/000183006.","journal-title":"Nephron"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<436::AID-AJMG14>3.0.CO;2-X","volume":"82","author":"IE Knol","year":"1999","unstructured":"Knol IE, Ausems MG, Lindhout D, et al: Different phenotypic expression in relatives with fabry disease caused by a W226X mutation. Am J Med Genet. 1999, 82: 436-439. 10.1002\/(SICI)1096-8628(19990219)82:5<436::AID-AJMG14>3.0.CO;2-X.","journal-title":"Am J Med Genet"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00467-004-1462-8","volume":"19","author":"L Tumer","year":"2004","unstructured":"Tumer L, Ezgu FS, Hasanoglu A, Dalgic B, Bakkaloglu SA, Memis L, Dursun A: The co-existence of Fabry and celiac diseases:a case report. Pediatr Nephrol. 2004, 19: 679-681. 10.1007\/s00467-004-1462-8.","journal-title":"Pediatr Nephrol"},{"key":"425_CR16","first-page":"655","volume":"37","author":"Y Hiraizumi","year":"1995","unstructured":"Hiraizumi Y, Kanoh M, Shigematsu H, Yamashina M, Kondo T: A case of Fabry\u2019s disease with granulomatous interstitial nephritis. Nippon Jinzo Gakkai Shi. 1995, 37: 655-661.","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"425_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000169023","volume":"16","author":"A Van Loo","year":"1996","unstructured":"Van Loo A, Vanholder R, Madsen K, Praet M, Kint J, De Paepe A, Messiaen L, Lameire N, Hasholt L, Sorensen SA, Ringoir S: Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure. Am J Nephrol. 1996, 16: 352-357. 10.1159\/000169023.","journal-title":"Am J Nephrol"},{"key":"425_CR18","first-page":"73","volume":"55","author":"HK Singh","year":"2001","unstructured":"Singh HK, Nickeleit V, Kriegsmann J, Harris AA, Jennette JC, Mihatsch MJ: Coexistence of Fabry\u2019s disease and necrotizing and crescentic glomerulonephritis. Clin Nephrol. 2001, 55: 73-79.","journal-title":"Clin Nephrol"},{"key":"425_CR19","first-page":"1303","volume":"36","author":"A Yoshida","year":"1994","unstructured":"Yoshida A, Morozumi K, Takeda A, Koyama K, Oikawa T: Fabry-like laminated myelin body associated with IgA nephropathy. Nippon Jinzo Gakkai Shi. 1994, 36: 1303-1307.","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"425_CR20","first-page":"385","volume":"22","author":"A Pisani","year":"2005","unstructured":"Pisani A, Sessa A, Sabbatini M, Andreucci MV, Fusco C, Balletta M, Cianciaruso B: Fabry nephropathy in a female with superposed IgA glomerulonephritis. G Ital Nefrol. 2005, 22: 385-389.","journal-title":"G Ital Nefrol"},{"key":"425_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ndtplus\/sfq108","volume":"3","author":"T Kakita","year":"2010","unstructured":"Kakita T, Nagatoya K, Mori T: Coincidental finding of Fabry\u2019s disease in a patient with IgA nephropathy. NDT Plus. 2010, 3: 443-446. 10.1093\/ndtplus\/sfq108.","journal-title":"NDT Plus"},{"key":"425_CR22","first-page":"71","volume":"47","author":"O Kawamura","year":"1997","unstructured":"Kawamura O, Sakuraba H, Itoh K, Suzuki Y, Doi M, Kuwabara H, Oshima S, Abe S, Warabi H, Yoshizawa N: Subclinical Fabry\u2019s disease occurring in the context of IgA nephropathy. Clin Nephrol. 1997, 47: 71-75.","journal-title":"Clin Nephrol"},{"issue":"5","key":"425_CR23","first-page":"682","volume":"22","author":"H Shimohata","year":"2009","unstructured":"Shimohata H, Yoh K, Takada K, Tanaka H, Usui J, Hirayama K, Kobayashi M, Yamagata K: Hemizygous Fabry disease associated with IgA nephropathy: a case report. J Nephrol. 2009, 22 (5): 682-684.","journal-title":"J Nephrol"},{"issue":"11","key":"425_CR24","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1007\/s00467-010-1500-7","volume":"25","author":"K Kiryluk","year":"2010","unstructured":"Kiryluk K, Julian BA, Wyatt RJ, Scolari F, Zhang H, Novak J, Gharavi AG: Genetic studies of IgA nephropathy: past, present, and future. Pediatr Nephrol. 2010, 25 (11): 2257-2268. 10.1007\/s00467-010-1500-7.","journal-title":"Pediatr Nephrol"},{"key":"425_CR25","doi-asserted-by":"publisher","first-page":"10,2369","DOI":"10.1186\/1471-2369-5-10","volume":"5","author":"YN Hall","year":"2004","unstructured":"Hall YN, Fuentes EF, Chertow GM, Olson JL: Race\/ethnicity and disease severity in IgA nephropathy. BMC Nephrol. 2004, 5: 10,2369-","journal-title":"BMC Nephrol"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1046\/j.1523-1755.2002.00477.x","volume":"62","author":"J Novak","year":"2002","unstructured":"Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M: Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int. 2002, 62: 465-475. 10.1046\/j.1523-1755.2002.00477.x.","journal-title":"Kidney Int"},{"key":"425_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","volume":"67","author":"J Novak","year":"2005","unstructured":"Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J: IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005, 67: 504-513. 10.1111\/j.1523-1755.2005.67107.x.","journal-title":"Kidney Int"},{"key":"425_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1046\/j.1365-2249.2002.01821.x","volume":"127","author":"FP Schena","year":"2002","unstructured":"Schena FP: For further infestigations in IgA nephropathy the approach from phenotype to genotype is welcome. Clin Exp Immunol. 2002, 127: 399-401. 10.1046\/j.1365-2249.2002.01821.x.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"425_CR29","doi-asserted-by":"publisher","first-page":"e1002765","DOI":"10.1371\/journal.pgen.1002765","volume":"8","author":"K Kiryluk","year":"2012","unstructured":"Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J, Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG: Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012, 8 (6): e1002765-10.1371\/journal.pgen.1002765. Epub 2012 Jun 21","journal-title":"PLoS Genet"},{"issue":"6","key":"425_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0161-5890(78)90130-X","volume":"15","author":"MN Hamers","year":"1978","unstructured":"Hamers MN, Donker-Koopman WE, Coulon-Morelec MJ, Dupouey P, Tager JM: Characterization of antibodies against ceramidetrihexoside and globoside. Immunochemistry. 1978, 15 (6): 353-358. 10.1016\/0161-5890(78)90130-X.","journal-title":"Immunochemistry"},{"key":"425_CR31","first-page":"906","volume-title":"The Metabolic Basis of Inherited Disease","author":"RJ Desnick","year":"1983","unstructured":"Desnick RJ, Sweeley CC: Fabry\u2019s disease:\u03b1-galactosidase A deficiency. The Metabolic Basis of Inherited Disease. Edited by: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS. 1983, NY: McGraw-Hill, 906-944. 5th","edition":"5th"},{"key":"425_CR32","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1016\/S0021-9258(18)37780-9","volume":"263","author":"S Shibata","year":"1988","unstructured":"Shibata S, Takeda T, Natori Y: The structure of nephritogenoside:a nephritogenic glycopeptide with \u03b1-N-glycosidic linkage. J Biol Chem. 1988, 263: 12483-12485.","journal-title":"J Biol Chem"},{"key":"425_CR33","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"RJ Desnick","year":"2001","unstructured":"Desnick RJ, Joannou YA, Eng CM: \u03b1-galactosidase A deficiency: Fabry Disease. The Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR, Beaudet AL, Sly WS, Valle D. 2001, New York, USA: McGraw-Hill, 3733-3774."},{"key":"425_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, St\u00f6rk S, Voelker W, Ertl G, Wanner C, Strotmann J: Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy:evidence for a better outcome with early treatment. Circulation. 2009, 119: 524-529. 10.1161\/CIRCULATIONAHA.108.794529.","journal-title":"Circulation"},{"key":"425_CR35","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F Breunig","year":"2006","unstructured":"Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C: Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int. 2006, 69: 1216-1221. 10.1038\/sj.ki.5000208.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:28:03Z","timestamp":1630531683000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,11]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-6","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,11]]},"assertion":[{"value":"7 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}